Posternak Blankstein & Lund LLP is now Arent Fox. Read the press release

Five Things CBD Insiders Are Looking for From the FDA

Arent Fox Associate Emily Leongini was quoted in the Hemp Industry Daily article, “Five things CBD insiders are looking for from the FDA,” published on May 21, 2019.

The article explores perspectives on FDA’s action regarding CBD enforcement, including the agency’s first hearing on CBD on May 31, 2019. Emily explained that the science and data behind CBD is crucial for the FDA and is hopeful that there may be more information out there. “What the FDA is really focused on, and what will inform the agency’s policy approach to regulating in this space, is the science. Where are the data? And so that’s what I’m going to be looking for.”


Read the full article here.


Continue Reading